Global Prostate Cancer Diagnostics Market Growth 2020-2025
According to this study, over the next five years the Prostate Cancer Diagnostics market will register a 7.6%% CAGR in terms of revenue, the global market size will reach $ 15200 million by 2025, from $ 11350 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Prostate Cancer Diagnostics business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Prostate Cancer Diagnostics market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Prostate Cancer Diagnostics, covering the supply chain analysis, impact assessment to the Prostate Cancer Diagnostics market size growth rate in several scenarios, and the measures to be undertaken by Prostate Cancer Diagnostics companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Tumor Biomarker Tests
Imaging
Biopsy
Other
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
age < 55
age 55-75
age > 75
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Genomic Health
Myriad Genetics
Abbott
Siemens Healthcare
DiaSorin
OPKO
MDx Health
BioMeriux
Beckman Coulter
Roche
Ambry Genetics
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Prostate Cancer Diagnostics consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Prostate Cancer Diagnostics market by identifying its various subsegments.
Focuses on the key global Prostate Cancer Diagnostics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Prostate Cancer Diagnostics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Prostate Cancer Diagnostics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Prostate Cancer Diagnostics Consumption 2015-2025
2.1.2 Prostate Cancer Diagnostics Consumption CAGR by Region
2.2 Prostate Cancer Diagnostics Segment by Type
2.2.1 Tumor Biomarker Tests
2.2.2 Imaging
2.2.3 Biopsy
2.2.4 Other
2.3 Prostate Cancer Diagnostics Consumption by Type
2.3.1 Global Prostate Cancer Diagnostics Consumption Market Share by Type (2015-2020)
2.3.2 Global Prostate Cancer Diagnostics Revenue and Market Share by Type (2015-2020)
2.3.3 Global Prostate Cancer Diagnostics Sale Price by Type (2015-2020)
2.4 Prostate Cancer Diagnostics Segment by Application
2.4.1 age < 55
2.4.2 age 55-75
2.4.3 age > 75
2.5 Prostate Cancer Diagnostics Consumption by Application
2.5.1 Global Prostate Cancer Diagnostics Consumption Market Share by Type (2015-2020)
2.5.2 Global Prostate Cancer Diagnostics Value and Market Share by Type (2015-2020)
2.5.3 Global Prostate Cancer Diagnostics Sale Price by Type (2015-2020)
3 Global Prostate Cancer Diagnostics by Company
3.1 Global Prostate Cancer Diagnostics Sales Market Share by Company
3.1.1 Global Prostate Cancer Diagnostics Sales by Company (2018-2020)
3.1.2 Global Prostate Cancer Diagnostics Sales Market Share by Company (2018-2020)
3.2 Global Prostate Cancer Diagnostics Revenue Market Share by Company
3.2.1 Global Prostate Cancer Diagnostics Revenue by Company (2018-2020)
3.2.2 Global Prostate Cancer Diagnostics Revenue Market Share by Company (2018-2020)
3.3 Global Prostate Cancer Diagnostics Sale Price by Company
3.4 Global Prostate Cancer Diagnostics Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Prostate Cancer Diagnostics Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Prostate Cancer Diagnostics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Prostate Cancer Diagnostics by Regions
4.1 Prostate Cancer Diagnostics by Regions
4.2 Americas Prostate Cancer Diagnostics Consumption Growth
4.3 APAC Prostate Cancer Diagnostics Consumption Growth
4.4 Europe Prostate Cancer Diagnostics Consumption Growth
4.5 Middle East & Africa Prostate Cancer Diagnostics Consumption Growth
5 Americas
5.1 Americas Prostate Cancer Diagnostics Consumption by Countries
5.1.1 Americas Prostate Cancer Diagnostics Consumption by Countries (2015-2020)
5.1.2 Americas Prostate Cancer Diagnostics Value by Countries (2015-2020)
5.2 Americas Prostate Cancer Diagnostics Consumption by Type
5.3 Americas Prostate Cancer Diagnostics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Prostate Cancer Diagnostics Consumption by Regions
6.1.1 APAC Prostate Cancer Diagnostics Consumption by Regions (2015-2020)
6.1.2 APAC Prostate Cancer Diagnostics Value by Regions (2015-2020)
6.2 APAC Prostate Cancer Diagnostics Consumption by Type
6.3 APAC Prostate Cancer Diagnostics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Prostate Cancer Diagnostics by Countries
7.1.1 Europe Prostate Cancer Diagnostics Consumption by Countries (2015-2020)
7.1.2 Europe Prostate Cancer Diagnostics Value by Countries (2015-2020)
7.2 Europe Prostate Cancer Diagnostics Consumption by Type
7.3 Europe Prostate Cancer Diagnostics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Prostate Cancer Diagnostics by Countries
8.1.1 Middle East & Africa Prostate Cancer Diagnostics Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Prostate Cancer Diagnostics Value by Countries (2015-2020)
8.2 Middle East & Africa Prostate Cancer Diagnostics Consumption by Type
8.3 Middle East & Africa Prostate Cancer Diagnostics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Prostate Cancer Diagnostics Distributors
10.3 Prostate Cancer Diagnostics Customer
11 Global Prostate Cancer Diagnostics Market Forecast
11.1 Global Prostate Cancer Diagnostics Consumption Forecast (2021-2025)
11.2 Global Prostate Cancer Diagnostics Forecast by Regions
11.2.1 Global Prostate Cancer Diagnostics Forecast by Regions (2021-2025)
11.2.2 Global Prostate Cancer Diagnostics Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Prostate Cancer Diagnostics Forecast by Type
11.8 Global Prostate Cancer Diagnostics Forecast by Application
12 Key Players Analysis
12.1 Genomic Health
12.1.1 Company Information
12.1.2 Prostate Cancer Diagnostics Product Offered
12.1.3 Genomic Health Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Genomic Health Latest Developments
12.2 Myriad Genetics
12.2.1 Company Information
12.2.2 Prostate Cancer Diagnostics Product Offered
12.2.3 Myriad Genetics Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Myriad Genetics Latest Developments
12.3 Abbott
12.3.1 Company Information
12.3.2 Prostate Cancer Diagnostics Product Offered
12.3.3 Abbott Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Abbott Latest Developments
12.4 Siemens Healthcare
12.4.1 Company Information
12.4.2 Prostate Cancer Diagnostics Product Offered
12.4.3 Siemens Healthcare Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Siemens Healthcare Latest Developments
12.5 DiaSorin
12.5.1 Company Information
12.5.2 Prostate Cancer Diagnostics Product Offered
12.5.3 DiaSorin Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 DiaSorin Latest Developments
12.6 OPKO
12.6.1 Company Information
12.6.2 Prostate Cancer Diagnostics Product Offered
12.6.3 OPKO Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 OPKO Latest Developments
12.7 MDx Health
12.7.1 Company Information
12.7.2 Prostate Cancer Diagnostics Product Offered
12.7.3 MDx Health Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 MDx Health Latest Developments
12.8 BioMeriux
12.8.1 Company Information
12.8.2 Prostate Cancer Diagnostics Product Offered
12.8.3 BioMeriux Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 BioMeriux Latest Developments
12.9 Beckman Coulter
12.9.1 Company Information
12.9.2 Prostate Cancer Diagnostics Product Offered
12.9.3 Beckman Coulter Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Beckman Coulter Latest Developments
12.10 Roche
12.10.1 Company Information
12.10.2 Prostate Cancer Diagnostics Product Offered
12.10.3 Roche Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Roche Latest Developments
12.11 Ambry Genetics
12.11.1 Company Information
12.11.2 Prostate Cancer Diagnostics Product Offered
12.11.3 Ambry Genetics Prostate Cancer Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Ambry Genetics Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Prostate Cancer Diagnostics Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Tumor Biomarker Tests
Table 5. Major Players of Imaging
Table 6. Major Players of Biopsy
Table 7. Major Players of Other
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Prostate Cancer Diagnostics Consumption Market Share by Type (2015-2020)
Table 10. Global Prostate Cancer Diagnostics Revenue by Type (2015-2020) ($ million)
Table 11. Global Prostate Cancer Diagnostics Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Prostate Cancer Diagnostics Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Prostate Cancer Diagnostics Consumption Market Share by Application (2015-2020)
Table 15. Global Prostate Cancer Diagnostics Value by Application (2015-2020)
Table 16. Global Prostate Cancer Diagnostics Value Market Share by Application (2015-2020)
Table 17. Global Prostate Cancer Diagnostics Sale Price by Application (2015-2020)
Table 18. Global Prostate Cancer Diagnostics Sales by Company (2017-2019) (K Units)
Table 19. Global Prostate Cancer Diagnostics Sales Market Share by Company (2017-2019)
Table 20. Global Prostate Cancer Diagnostics Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Prostate Cancer Diagnostics Revenue Market Share by Company (2017-2019)
Table 22. Global Prostate Cancer Diagnostics Sale Price by Company (2017-2019)
Table 23. Global Prostate Cancer Diagnostics Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Prostate Cancer Diagnostics Products Offered
Table 25. Prostate Cancer Diagnostics Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Prostate Cancer Diagnostics Consumption by Regions 2015-2020 (K Units)
Table 27. Global Prostate Cancer Diagnostics Consumption Market Share by Regions 2015-2020
Table 28. Global Prostate Cancer Diagnostics Value by Regions 2015-2020 ($ Millions)
Table 29. Global Prostate Cancer Diagnostics Value Market Share by Regions 2015-2020
Table 30. Americas Prostate Cancer Diagnostics Consumption by Countries (2015-2020) (K Units)
Table 31. Americas Prostate Cancer Diagnostics Consumption Market Share by Countries (2015-2020)
Table 32. Americas Prostate Cancer Diagnostics Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Prostate Cancer Diagnostics Value Market Share by Countries (2015-2020)
Table 34. Americas Prostate Cancer Diagnostics Consumption by Type (2015-2020) (K Units)
Table 35. Americas Prostate Cancer Diagnostics Consumption Market Share by Type (2015-2020)
Table 36. Americas Prostate Cancer Diagnostics Consumption by Application (2015-2020) (K Units)
Table 37. Americas Prostate Cancer Diagnostics Consumption Market Share by Application (2015-2020)
Table 38. APAC Prostate Cancer Diagnostics Consumption by Countries (2015-2020) (K Units)
Table 39. APAC Prostate Cancer Diagnostics Consumption Market Share by Countries (2015-2020)
Table 40. APAC Prostate Cancer Diagnostics Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Prostate Cancer Diagnostics Value Market Share by Regions (2015-2020)
Table 42. APAC Prostate Cancer Diagnostics Consumption by Type (2015-2020) (K Units)
Table 43. APAC Prostate Cancer Diagnostics Consumption Market Share by Type (2015-2020)
Table 44. APAC Prostate Cancer Diagnostics Consumption by Application (2015-2020) (K Units)
Table 45. APAC Prostate Cancer Diagnostics Consumption Market Share by Application (2015-2020)
Table 46. Europe Prostate Cancer Diagnostics Consumption by Countries (2015-2020) (K Units)
Table 47. Europe Prostate Cancer Diagnostics Consumption Market Share by Countries (2015-2020)
Table 48. Europe Prostate Cancer Diagnostics Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Prostate Cancer Diagnostics Value Market Share by Countries (2015-2020)
Table 50. Europe Prostate Cancer Diagnostics Consumption by Type (2015-2020) (K Units)
Table 51. Europe Prostate Cancer Diagnostics Consumption Market Share by Type (2015-2020)
Table 52. Europe Prostate Cancer Diagnostics Consumption by Application (2015-2020) (K Units)
Table 53. Europe Prostate Cancer Diagnostics Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Prostate Cancer Diagnostics Consumption by Countries (2015-2020) (K Units)
Table 55. Middle East & Africa Prostate Cancer Diagnostics Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Prostate Cancer Diagnostics Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Prostate Cancer Diagnostics Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Prostate Cancer Diagnostics Consumption by Type (2015-2020) (K Units)
Table 59. Middle East & Africa Prostate Cancer Diagnostics Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Prostate Cancer Diagnostics Consumption by Application (2015-2020) (K Units)
Table 61. Middle East & Africa Prostate Cancer Diagnostics Consumption Market Share by Application (2015-2020)
Table 62. Prostate Cancer Diagnostics Distributors List
Table 63. Prostate Cancer Diagnostics Customer List
Table 64. Global Prostate Cancer Diagnostics Consumption Forecast by Countries (2021-2025) (K Units)
Table 65. Global Prostate Cancer Diagnostics Consumption Market Forecast by Regions
Table 66. Global Prostate Cancer Diagnostics Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Prostate Cancer Diagnostics Value Market Share Forecast by Regions
Table 68. Global Prostate Cancer Diagnostics Consumption Forecast by Type (2021-2025) (K Units)
Table 69. Global Prostate Cancer Diagnostics Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Prostate Cancer Diagnostics Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Prostate Cancer Diagnostics Value Market Share Forecast by Type (2021-2025)
Table 72. Global Prostate Cancer Diagnostics Consumption Forecast by Application (2021-2025) (K Units)
Table 73. Global Prostate Cancer Diagnostics Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Prostate Cancer Diagnostics Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Prostate Cancer Diagnostics Value Market Share Forecast by Application (2021-2025)
Table 76. Genomic Health Product Offered
Table 77. Genomic Health Prostate Cancer Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 78. Genomic Health Main Business
Table 79. Genomic Health Latest Developments
Table 80. Genomic Health Basic Information, Company Total Revenue (in $ million), Prostate Cancer Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 81. Myriad Genetics Product Offered
Table 82. Myriad Genetics Prostate Cancer Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 83. Myriad Genetics Main Business
Table 84. Myriad Genetics Latest Developments
Table 85. Myriad Genetics Basic Information, Company Total Revenue (in $ million), Prostate Cancer Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 86. Abbott Product Offered
Table 87. Abbott Prostate Cancer Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 88. Abbott Main Business
Table 89. Abbott Latest Developments
Table 90. Abbott Basic Information, Company Total Revenue (in $ million), Prostate Cancer Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 91. Siemens Healthcare Product Offered
Table 92. Siemens Healthcare Prostate Cancer Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 93. Siemens Healthcare Main Business
Table 94. Siemens Healthcare Latest Developments
Table 95. Siemens Healthcare Basic Information, Company Total Revenue (in $ million), Prostate Cancer Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 96. DiaSorin Product Offered
Table 97. DiaSorin Prostate Cancer Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 98. DiaSorin Main Business
Table 99. DiaSorin Latest Developments
Table 100. DiaSorin Basic Information, Company Total Revenue (in $ million), Prostate Cancer Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 101. OPKO Product Offered
Table 102. OPKO Prostate Cancer Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 103. OPKO Main Business
Table 104. OPKO Latest Developments
Table 105. OPKO Basic Information, Company Total Revenue (in $ million), Prostate Cancer Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 106. MDx Health Product Offered
Table 107. MDx Health Basic Information, Company Total Revenue (in $ million), Prostate Cancer Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 108. MDx Health Main Business
Table 109. MDx Health Latest Developments
Table 110. MDx Health Prostate Cancer Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 111. BioMeriux Product Offered
Table 112. BioMeriux Prostate Cancer Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 113. BioMeriux Main Business
Table 114. BioMeriux Latest Developments
Table 115. BioMeriux Basic Information, Company Total Revenue (in $ million), Prostate Cancer Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 116. Beckman Coulter Product Offered
Table 117. Beckman Coulter Prostate Cancer Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 118. Beckman Coulter Main Business
Table 119. Beckman Coulter Latest Developments
Table 120. Beckman Coulter Basic Information, Company Total Revenue (in $ million), Prostate Cancer Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 121. Roche Product Offered
Table 122. Roche Prostate Cancer Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 123. Roche Main Business
Table 124. Roche Latest Developments
Table 125. Roche Basic Information, Company Total Revenue (in $ million), Prostate Cancer Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 126. Ambry Genetics Product Offered
Table 127. Ambry Genetics Prostate Cancer Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 128. Ambry Genetics Main Business
Table 129. Ambry Genetics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 130. Ambry Genetics Latest Developments
List of Figures
Figure 1. Picture of Prostate Cancer Diagnostics
Figure 2. Prostate Cancer Diagnostics Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Prostate Cancer Diagnostics Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Prostate Cancer Diagnostics Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Tumor Biomarker Tests
Figure 7. Product Picture of Imaging
Figure 8. Product Picture of Biopsy
Figure 9. Product Picture of Other
Figure 10. Global Prostate Cancer Diagnostics Consumption Market Share by Type (2015-2020)
Figure 11. Global Prostate Cancer Diagnostics Value Market Share by Type (2015-2020)
Figure 12. Prostate Cancer Diagnostics Consumed in age < 55
Figure 13. Global Prostate Cancer Diagnostics Market: age < 55 (2015-2020) (K Units)
Figure 14. Global Prostate Cancer Diagnostics Market: age < 55 (2015-2020) ($ Millions)
Figure 15. Prostate Cancer Diagnostics Consumed in age 55-75
Figure 16. Global Prostate Cancer Diagnostics Market: age 55-75 (2015-2020) (K Units)
Figure 17. Global Prostate Cancer Diagnostics Market: age 55-75 (2015-2020) ($ Millions)
Figure 18. Prostate Cancer Diagnostics Consumed in age > 75
Figure 19. Global Prostate Cancer Diagnostics Market: age > 75 (2015-2020) (K Units)
Figure 20. Global Prostate Cancer Diagnostics Market: age > 75 (2015-2020) ($ Millions)
Figure 21. Global Prostate Cancer Diagnostics Consumption Market Share by Application (2015-2020)
Figure 22. Global Prostate Cancer Diagnostics Value Market Share by Application (2015-2020)
Figure 23. Global Prostate Cancer Diagnostics Sales Market Share by Company in 2017
Figure 24. Global Prostate Cancer Diagnostics Sales Market Share by Company in 2019
Figure 25. Global Prostate Cancer Diagnostics Revenue Market Share by Company in 2017
Figure 26. Global Prostate Cancer Diagnostics Revenue Market Share by Company in 2019
Figure 27. Global Prostate Cancer Diagnostics Sale Price by Company in 2019
Figure 28. Global Prostate Cancer Diagnostics Consumption Market Share by Regions 2015-2020
Figure 29. Global Prostate Cancer Diagnostics Value Market Share by Regions 2015-2020
Figure 30. Americas Prostate Cancer Diagnostics Consumption 2015-2020 (K Units)
Figure 31. Americas Prostate Cancer Diagnostics Value 2015-2020 ($ Millions)
Figure 32. APAC Prostate Cancer Diagnostics Consumption 2015-2020 (K Units)
Figure 33. APAC Prostate Cancer Diagnostics Value 2015-2020 ($ Millions)
Figure 34. Europe Prostate Cancer Diagnostics Consumption 2015-2020 (K Units)
Figure 35. Europe Prostate Cancer Diagnostics Value 2015-2020 ($ Millions)
Figure 36. Middle East & Africa Prostate Cancer Diagnostics Consumption 2015-2020 (K Units)
Figure 37. Middle East & Africa Prostate Cancer Diagnostics Value 2015-2020 ($ Millions)
Figure 38. Americas Prostate Cancer Diagnostics Consumption Market Share by Countries in 2019
Figure 39. Americas Prostate Cancer Diagnostics Value Market Share by Countries in 2019
Figure 40. Americas Prostate Cancer Diagnostics Consumption Market Share by Type in 2019
Figure 41. Americas Prostate Cancer Diagnostics Consumption Market Share by Application in 2019
Figure 42. United States Prostate Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 43. United States Prostate Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 44. Canada Prostate Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 45. Canada Prostate Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 46. Mexico Prostate Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 47. Mexico Prostate Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 48. APAC Prostate Cancer Diagnostics Consumption Market Share by Countries in 2019
Figure 49. APAC Prostate Cancer Diagnostics Value Market Share by Regions in 2019
Figure 50. APAC Prostate Cancer Diagnostics Consumption Market Share by Type in 2019
Figure 51. APAC Prostate Cancer Diagnostics Consumption Market Share by Application in 2019
Figure 52. China Prostate Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 53. China Prostate Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 54. Japan Prostate Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 55. Japan Prostate Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 56. Korea Prostate Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 57. Korea Prostate Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 58. Southeast Asia Prostate Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 59. Southeast Asia Prostate Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 60. India Prostate Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 61. India Prostate Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 62. Australia Prostate Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 63. Australia Prostate Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 64. Europe Prostate Cancer Diagnostics Consumption Market Share by Countries in 2019
Figure 65. Europe Prostate Cancer Diagnostics Value Market Share by Countries in 2019
Figure 66. Europe Prostate Cancer Diagnostics Consumption Market Share by Type in 2019
Figure 67. Europe Prostate Cancer Diagnostics Consumption Market Share by Application in 2019
Figure 68. Germany Prostate Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 69. Germany Prostate Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 70. France Prostate Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 71. France Prostate Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 72. UK Prostate Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 73. UK Prostate Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 74. Italy Prostate Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 75. Italy Prostate Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 76. Russia Prostate Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 77. Russia Prostate Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 78. Middle East & Africa Prostate Cancer Diagnostics Consumption Market Share by Countries in 2019
Figure 79. Middle East & Africa Prostate Cancer Diagnostics Value Market Share by Countries in 2019
Figure 80. Middle East & Africa Prostate Cancer Diagnostics Consumption Market Share by Type in 2019
Figure 81. Middle East & Africa Prostate Cancer Diagnostics Consumption Market Share by Application in 2019
Figure 82. Egypt Prostate Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 83. Egypt Prostate Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 84. South Africa Prostate Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 85. South Africa Prostate Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 86. Israel Prostate Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 87. Israel Prostate Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 88. Turkey Prostate Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 89. Turkey Prostate Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 90. GCC Countries Prostate Cancer Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 91. GCC Countries Prostate Cancer Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 92. Global Prostate Cancer Diagnostics Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 93. Global Prostate Cancer Diagnostics Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 94. Americas Prostate Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 95. Americas Prostate Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 96. APAC Prostate Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 97. APAC Prostate Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 98. Europe Prostate Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 99. Europe Prostate Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 100. Middle East & Africa Prostate Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 101. Middle East & Africa Prostate Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 102. United States Prostate Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 103. United States Prostate Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 104. Canada Prostate Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 105. Canada Prostate Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 106. Mexico Prostate Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 107. Mexico Prostate Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 108. Brazil Prostate Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 109. Brazil Prostate Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 110. China Prostate Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 111. China Prostate Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 112. Japan Prostate Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 113. Japan Prostate Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 114. Korea Prostate Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 115. Korea Prostate Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 116. Southeast Asia Prostate Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 117. Southeast Asia Prostate Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 118. India Prostate Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 119. India Prostate Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 120. Australia Prostate Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 121. Australia Prostate Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 122. Germany Prostate Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 123. Germany Prostate Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 124. France Prostate Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 125. France Prostate Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 126. UK Prostate Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 127. UK Prostate Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 128. Italy Prostate Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 129. Italy Prostate Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 130. Russia Prostate Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 131. Russia Prostate Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 132. Spain Prostate Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 133. Spain Prostate Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 134. Egypt Prostate Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 135. Egypt Prostate Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 136. South Africa Prostate Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 137. South Africa Prostate Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 138. Israel Prostate Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 139. Israel Prostate Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 140. Turkey Prostate Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 141. Turkey Prostate Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 142. GCC Countries Prostate Cancer Diagnostics Consumption 2021-2025 (K Units)
Figure 143. GCC Countries Prostate Cancer Diagnostics Value 2021-2025 ($ Millions)
Figure 144. Genomic Health Prostate Cancer Diagnostics Market Share (2018-2020)
Figure 145. Myriad Genetics Prostate Cancer Diagnostics Market Share (2018-2020)
Figure 146. Abbott Prostate Cancer Diagnostics Market Share (2018-2020)
Figure 147. Siemens Healthcare Prostate Cancer Diagnostics Market Share (2018-2020)
Figure 148. DiaSorin Prostate Cancer Diagnostics Market Share (2018-2020)
Figure 149. OPKO Prostate Cancer Diagnostics Market Share (2018-2020)
Figure 150. MDx Health Prostate Cancer Diagnostics Market Share (2018-2020)
Figure 151. BioMeriux Prostate Cancer Diagnostics Market Share (2018-2020)
Figure 152. Beckman Coulter Prostate Cancer Diagnostics Market Share (2018-2020)
Figure 153. Roche Prostate Cancer Diagnostics Market Share (2018-2020)
Figure 154. Ambry Genetics Prostate Cancer Diagnostics Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets